<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Inclusion Body Myositis: Clonal Expansions of Muscle-Infiltrating T Cells Persist Over Time</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2003-08">2003-08</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">K</forename><surname>Muntzing</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A-R</forename><surname>Moslemi</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">A</forename><surname>Oldfors</surname></persName>
							<email>anders.oldfors@path.gu.se</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pathology</orgName>
								<orgName type="department" key="dep2">yDepartment of Neurology</orgName>
								<orgName type="institution">Sahlgrenska University Hospital</orgName>
								<address>
									<addrLine>Go ¨teborg</addrLine>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University Hospital</orgName>
								<address>
									<addrLine>SE-413 45 Go ¨teborg</addrLine>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">by University Of Illinois At Urbana Champaign</orgName>
								<address>
									<addrLine>Wiley Online Library on [08</addrLine>
									<country>03</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Inclusion Body Myositis: Clonal Expansions of Muscle-Infiltrating T Cells Persist Over Time</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Scandinavian Journal of Immunology</title>
						<title level="j" type="abbrev">Scand J Immunol</title>
						<idno type="ISSN">0300-9475</idno>
						<idno type="eISSN">1365-3083</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">58</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page" from="195" to="200"/>
							<date type="published" when="2003-08" />
						</imprint>
					</monogr>
					<idno type="MD5">2ACBB80043BE8561F463793DF459E81D</idno>
					<idno type="DOI">10.1046/j.1365-3083.2003.01251.x</idno>
					<note type="submission">Received 3 December 2002; Accepted in revised form 4 February 2003</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Inclusion body myositis (IBM) is a chronic inflammatory myopathy. The muscle histology is characterized by infiltration of T cells, which invade and apparently destroy muscle fibres. This study was performed to investigate whether predominant clones of muscle-infiltrating T cells are identical in different muscles and whether they persist over time in IBM. By reverse transcriptase-polymerase chain reaction, 25 T-cell receptor (TCR) variable b (Vb) chain families and the complementarity-determining region 3 (CDR3) of the TCR were analysed in two different muscle biopsies of four patients with IBM. In two of the patients, the muscle biopsies were obtained from different muscles at one time point, whereas in two patients, the second biopsy was obtained 9 years after the first biopsy. T cells expressing predominant Vb families were analysed for clonality by fragment length analysis of the CDR3. Predominant Vb families were analysed by DNA sequencing to identify identical clones. Immunohistochemical staining of Vb families was performed to study the distribution of T cells expressing identified predominant Vb families. The muscle-infiltrating lymphocytes showed restricted expression of TCR Vb families. DNA sequencing proved that clonally expanded T cells were identical in different muscles and persisted 9 years after the first biopsy. Immunohistochemical analysis with Vb family-specific antibodies demonstrated the endomysial localization of these T cells in inflammatory cell infiltrates. Our results show that in IBM there is clonal restriction of TCR expression in muscle-infiltrating lymphocytes. Identical T-cell clones predominate in different muscles, and these clones persist for many years. These results indicate an important, continuous, antigen-driven inflammatory reaction in IBM.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Inclusion body myositis (IBM) is a chronic, progressive, inflammatory muscle disease mainly affecting individuals older than 50 years <ref type="bibr" target="#b0">[1]</ref>. Clinically, IBM is characterized by proximal and distal muscle weakness and wasting, frequently accompanied by dysphagia <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>. IBM, after several years of slowly progressive course, is a severely disabling disorder and there is no curative treatment. Muscle morphology is characterized by inflammatory cell infiltrates, which invade and apparently destroy non-necrotic muscle fibres <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>. In addition, there are rimmed vacuoles and congophilic inclusions in muscle fibres <ref type="bibr" target="#b6">[7]</ref>. Deposits of 15-18 nm of tubulo-filaments are present in cytoplasm and nuclei. Accumulation of various proteins have been described in association with the rimmed vacuoles <ref type="bibr" target="#b7">[8]</ref>.</p><p>In spite of resistance to immunosuppressive treatment, there is evidence that the inflammatory reaction is important in IBM <ref type="bibr" target="#b8">[9]</ref>. The inflammatory cells are mainly composed of T cells and macrophages, and non-necrotic muscle fibres are invaded by inflammatory cells, most of which are CD8 þ T cells <ref type="bibr" target="#b3">[4]</ref>. Muscle fibres invaded by T cells are several times more frequent than fibres displaying other pathologic alterations such as congophilic inclusions <ref type="bibr" target="#b9">[10]</ref>. A large proportion of the autoinvasive CD8 þ T cells are human leucocyte antigen-DR (HLA-DR)-positive suggesting that they are activated <ref type="bibr" target="#b10">[11]</ref>. All invaded muscle cells express HLA class I antigen on their surface, which is consistent with a major histocompatibility complex (MHC) class I-restricted cytotoxic cell-mediated attack on muscle fibres. Inflammatory cell-infiltrates in IBM exhibit a restricted expression of the variable a/b (Va/b) chain families of the T-cell receptor (TCR) <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref>, and there are clonal expansions of muscle-infiltrating T cells <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>.</p><p>If specific antigens in muscle trigger the inflammatory reaction, it would be expected that T cell-expressing identical TCRs are expressed in all muscles and also persist over time. In this study, we investigated the predominant T-cell clones of muscle-infiltrating lymphocytes in different muscles obtained at one time point and in repeat muscle biopsies obtained 9 years apart. The results show that the TCR expression is restricted and that predominant T-cell clones are identical in different muscles and persist for many years.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p>Patients. Muscle specimens from four patients with IBM were studied. The patients had progressive muscle weakness and the diagnostic changes of definite IBM, according to Griggs et al. <ref type="bibr" target="#b17">[18]</ref>. A summary of clinical data is summarized in Table <ref type="table" target="#tab_0">1</ref>. The muscle tissue specimens were obtained by open biopsy and immediately frozen in a mixture of propane and propylene chilled by liquid nitrogen and kept at À85 C until analysed. Specimens from two different mus-cles were obtained at the same time point in patient 1 and 2. In patient 3 and 4, the two muscle biopsies were obtained with a time interval of 9 years.</p><p>Polymerase chain reaction and fragment analysis. Total RNA from muscle tissue was extracted by using the SV Total RNA Isolation System (Promega, Madison, WI, USA). First strand cDNA was synthesized by Ready To Go you-prime first-strand beads with molony murine leukaemia virus (M-MuLV) reverse transcriptase and the oligonucleotide pd(T) 12À18 as primer (Pharmacia Amersham Biotech, Uppsala, Sweden). Polymerase chain reaction (PCR) analysis of the complementarity-determining region 3 (CDR3) using 25 different Vb family-specific primers was performed as previously described <ref type="bibr" target="#b15">[16]</ref>. Predominant Vb families in both muscles from each case were selected for further analysis of the CDR3 region by fragment analysis using a Cb primer conjugated to the fluorescent dye 6-FAM (KEBO Laboratory, Stockholm, Sweden) as previously described <ref type="bibr" target="#b15">[16]</ref>. The labelled PCR products were loaded on a 5.75% polyacrylamide-sequencing gel (Long Ranger Singel Packs, FMC Bioproducts, Rockland, Maine, UK) and run on an automated DNA sequencer (Model 377 DNA Sequencer, Applied Biosystems, Foster City, CA, USA) to separate CDR3 fragments of various length. The results were analysed by GeneScan TM Analysis software (Perkin Elmer, Foster City, CA, USA). As the positions of the Vb and the Cb primers were fixed, the length distribution observed in the PCR products only depended on the size of the CDR3 region, which was set according to Moss <ref type="bibr" target="#b18">[19]</ref>.</p><p>Cloning and sequencing. Predominant PCR products of the different Vb families were further analysed by sequencing to identify identical clones. The PCR fragments were sequenced directly or after subcloning with TOPO TA Cloning Kit, Dual Promoter (Invitogen BV, Groningen, The Netherlands). The plasmid inserts of randomly selected colonies were amplified by PCR and then purified using Micro Spin columns (Pharmacia Amersham Biotech). Automatic sequencing was performed with a 377 DNA Sequencer (Applied Biosystems) using ABI PRISM BigDye TM Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions.</p><p>Immunohistochemical staining of Vb families. Cryostat sections were fixed in cold acetone for 5 min, washed in phosphate-buffered saline (PBS) and treated with 0.3% H 2 O 2 for 5 min. They were then incubated in PBS with 4% PBS/bovine serum albumin (BSA) for 10 min followed by incubation with a mouse monoclonal antibody to Vb8 or Vb5.1 (Beckman-Coulter, Bromma, Sweden) diluted 1 : 200 in 1% PBS/BSA for 1 h. After rinsing in PBS, the sections were treated with a biotinylated rabbit antimouse secondary antibody for 30 min (Dako, Glostrup, Denmark). The binding of biotinylated antibodies was detected following stepwise incubation with avidin-biotin-peroxidase complexes (Dako) and 3,3 0 -diaminobenzidine tetrahydrochloride as a chromogen.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>A restricted usage of Vb families in muscle-infiltrating lymphocytes was found in all eight examined muscle biopsies. The results from patient 1 are illustrated in Fig. <ref type="figure" target="#fig_0">1</ref>. One or more Vb family predominated in both muscle samples of each patient, and these were chosen for analysis of oligoclonal expansions by fragment size analysis. The results of the selected and analysed Vb families in patient 1 (Vb2, 4, 6, 8, 14 and 18) are illustrated in Fig. <ref type="figure" target="#fig_2">2</ref>. In this patient, the Vb8 family showed an oligoclonal pattern in both muscles, whereas the other Vb families showed a polyclonal pattern. In patients 2-4, a similar variability was observed. We then characterized the predominant CDR3 of TCR Vb8 in patients 1, 2 and 4, the Vb5.1 in patients 2 and 3 and Vb6 in patient 3 by DNA sequencing. The results show that identical T-cell clones were present in both investigated muscles of all four patients. The deduced amino acid sequences of the identified clones are presented in Fig. <ref type="figure" target="#fig_1">3</ref>. To study the localization of the investigated T cells within the tissue, we performed immunohistochemical analysis using Vb family-specific antibodies. We found that Vb8-expressing T cells of patient 1 and 4 and the Vb5.1-expressing T cells of patient 2 and 3 were present at high frequency in endomysial T-cell infiltrates (Fig. <ref type="figure" target="#fig_3">4</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In this study, we have demonstrated that muscle-infiltrating T cells show restricted Vb TCR expression and expansion of Tcell clones that are identical in different muscles and persist over very long time in patients with IBM.</p><p>TCR expression of muscle-infiltrating T cells has previously been studied in single muscle biopsies in IBM and polymyositis (PM) by analysis of the TCR Vb repertoire and the CDR3. Results from such studies have demonstrated restricted usage of Vb families <ref type="bibr">[12-14, 20, 21]</ref> and clonal expansions of T cells in muscle in IBM and PM <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b21">22]</ref>. The preferentially expressed Vb families varied between different studies and also between individual patients. However, Vb1, 3, 5.1, 5.2, 6 and 8 were reported as being frequently expressed <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b21">22]</ref>. The pattern of Vb family expression in muscle-infiltrating lymphocytes is different from peripheral blood <ref type="bibr" target="#b11">[12]</ref>. presented by MHC I-expressing muscle cells. In addition, Bender et al. <ref type="bibr" target="#b16">[17]</ref> showed that the autoinvasive T cells were clonally restricted, whereas the noninvasive interstitial T cells were clonally diverse in IBM, providing further evidence for an antigen-driven MHC-restricted immune response.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Such restricted Vb family expression and clonal expansions of T cells in muscle in IBM and PM indicate an antigendriven immune response with a limited number of antigens</head><p>Specific stimulation of naive T cells requires TCR interaction with an antigen presented by MHC class I or II, interaction between CD28 on T cells with costimulatory molecules belonging to the B7 family and other factors. Mature muscle cells do not express B7-1/B7-2 neither normally nor in inflammatory myopathies <ref type="bibr" target="#b22">[23]</ref>, but another functional costimulatory molecule (BB-1) has been demonstrated to be expressed by muscle fibers in inflammatory myopathies including IBM <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref>. This finding indicates that muscle cells may act as antigenpresenting cells to T cells with specific TCR rearrangements.</p><p>Because there is no efficient immunosuppressive treatment of IBM, the concept of IBM as an autoimmune disease has been debated. The importance of the inflammatory reaction in the pathogenesis of IBM is supported </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Vβ2</head><p>V β4 V β6 V β8 V β14 Vβ18 by several observations. Non-necrotic muscle fibres invaded by T cells are several-fold more frequent than fibres displaying other pathologic alterations such as congophilic inclusions <ref type="bibr" target="#b9">[10]</ref>. Upregulation of MHC class I is consistently found in IBM muscle biopsies irrespective of presence or absence of inflammatory cell infiltration <ref type="bibr" target="#b25">[26]</ref>. In addition, several genetic studies on IBM have shown a strong association with the HLA-DR3 haplotype <ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>, supporting the concept that autoimmunity is important in the pathogenesis of IBM. The mechanisms by which the T cells destroy the muscle fibres are not known. There are two major pathways of T-cell-mediated cell death. One is the perforin/granzyme pathway and the other is the Fas/Fas ligand pathway <ref type="bibr" target="#b29">[30]</ref>. Both mechanisms may act by induction of apoptosis. In polymyositis and IBM, perforin-positive cells have been demonstrated in association with invasion of non-necrotic muscle fibres <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>. Fas is not normally expressed by muscle fibres but is expressed by muscle fibres in IBM and PM <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b33">34]</ref>. However, apoptosis of muscle cells has not been shown to be of significance in IBM and PM <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>, although a recent study indicates that apoptosis occurs in muscle cells in inflammatory myopathies <ref type="bibr" target="#b37">[38]</ref>. Cytokines that are expressed or induced by the inflammatory cells may also be important in the pathogenesis of muscle fibre atrophy and destruction <ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref>.</p><p>In chronic inflammatory diseases like IBM, it is probable that the T-cell usage eventually becomes more diverse. In experimental allergic encephalomyelitis, there is initially a restricted T-cell usage, which eventually becomes more diverse, although the initial pathogenic T-cell clones remain and predominate in the inflammatory cell infiltrate <ref type="bibr" target="#b41">[42]</ref>. We found that the predominant T-cell clones in muscle-infiltrating lymphocytes persisted for at least 9 years. This is in accordance with a report where three IBM patients were followed for up to 22 months <ref type="bibr" target="#b42">[43]</ref>. This finding strongly indicates that a limited number of important antigens continuously drive the inflammatory reaction in IBM leading to progressive muscle destruction and weakness. Identification of the antigens recognized by these T-cell clones would give important insights in the pathogenesis of IBM. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A B C D</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Figure1Reverse transcriptase-polymerase chain reaction analysis of T-cell receptor variable b (Vb) family usage in muscle-infiltrating lymphocytes from patient 1 with inclusion body myositis and in peripheral blood lymphocytes (PBL) from a healthy control. The different Vb families are indicated above each lane. There is a restricted but variable usage of the different Vb families. Some of the Vb families appear as strong bands in both muscles, e.g. Vb2, 4, 6, 8, 14 and 18.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3</head><label>3</label><figDesc>Figure 3  Results from DNA sequencing of reverse transcriptase-polymerase chain reaction amplified fragments of predominant variable b families. Direct sequencing and/or subcloning before sequencing shows that there are identical T-cell clones in the different muscle specimens in each patient. The results are given as deduced amino acid sequences of the complementarity-determining region 3 (CDR3). In patient 3 and 4, there are 9 years between the 1st and 2nd biopsy in each case. The figure includes only clones that were identified in two different muscles or at two different occasions.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2</head><label>2</label><figDesc>Figure 2 Spectratyping of predominant variable b (Vb) families in patient 1. Vb8 shows only one peak in both muscles, indicating that the Vb8-expressing T cells in both muscles include one predominant clone.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4</head><label>4</label><figDesc>Figure 4 Haematoxylin and eosin (HE) staining (A and C) and immunohistochemical staining of the T cells expressing T-cell receptor variable b 8 (Vb8) chain (B and D) that were found to be predominant and oligoclonal in patient 1 (A and B) and 4 (C and D). The analysis shows that the Vb8-expressing T cells are located in endomysial inflammatory cell infiltrates. Bars correspond to 10 mm.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Clinical and morphological data on the inclusion body myositis (IBM) patients included in the study</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Duration of</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Gender</cell><cell>Age</cell><cell>symptoms</cell><cell>Main clinical</cell><cell></cell><cell></cell><cell>Degree of muscle</cell><cell></cell></row><row><cell>Patient</cell><cell>(M/F)</cell><cell>(years)</cell><cell>(years)</cell><cell>findings</cell><cell cols="2">CK* Treatment</cell><cell>inflammation</cell><cell>HLA</cell></row><row><cell>1</cell><cell>M</cell><cell>67</cell><cell>4</cell><cell>Weakness of elbow</cell><cell>10</cell><cell>None</cell><cell>Biceps: moderate</cell><cell>HLA-A*02</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion and long finger</cell><cell></cell><cell></cell><cell>inflammation.</cell><cell>B*08,51</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexors. Quadriceps</cell><cell></cell><cell></cell><cell>Quadriceps femoris:</cell><cell>DRB1*03,11</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>muscle atrophy</cell><cell></cell><cell></cell><cell>severe inflammation</cell><cell></cell></row><row><cell>2</cell><cell>M</cell><cell>60</cell><cell>5</cell><cell>Severe weakness of</cell><cell>15</cell><cell>None</cell><cell>Deltoid:</cell><cell>HLA-A*03,33</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>long finger flexors.</cell><cell></cell><cell></cell><cell>moderate inflammation.</cell><cell>B*14,51</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Moderate weakness in</cell><cell></cell><cell></cell><cell>Quadriceps femoris:</cell><cell>DRB1*01,03</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>knee extension, hip</cell><cell></cell><cell></cell><cell>moderate inflammation</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion and neck flexion</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>3</cell><cell>F</cell><cell>60</cell><cell>6</cell><cell>Weakness in knee</cell><cell cols="2">3.0 None</cell><cell>Deltoid: moderate</cell><cell>HLA-A*03,26;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>extension, hip flexion</cell><cell></cell><cell></cell><cell>inflammation</cell><cell>B*07,51</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>and finger flexion.</cell><cell></cell><cell></cell><cell></cell><cell>DRB1*01,13</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Swallowing difficulties</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>69</cell><cell>15</cell><cell>Severe weakness in</cell><cell cols="2">1.4 Prednisone since age</cell><cell>Deltoid: slight</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>knee extension, hip</cell><cell></cell><cell>60. Dosage: 15 mg/2</cell><cell>inflammation</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion and finger flexion.</cell><cell></cell><cell>days since age 66.</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Moderate to severe</cell><cell></cell><cell>Methotrexate</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>swallowing difficulties</cell><cell></cell><cell>5 mg/week</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>since age 68</cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>M</cell><cell>73</cell><cell>2</cell><cell>Weakness in knee</cell><cell>14</cell><cell>None</cell><cell>Gastrocnemius:</cell><cell>HLA-A*03,29;</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>extension, hip</cell><cell></cell><cell></cell><cell>severe inflammation</cell><cell>B*07,44</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion and finger flexion</cell><cell></cell><cell></cell><cell></cell><cell>DRB1*11,13</cell></row><row><cell></cell><cell></cell><cell>82</cell><cell>11</cell><cell>Severe weakness in</cell><cell cols="2">4.5 Prednisone since</cell><cell>Deltoid:</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>knee extension, hip</cell><cell></cell><cell>age 73. Dosage:</cell><cell>severe inflammation</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion and finger</cell><cell></cell><cell>10 mg/3 days</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>flexion. Moderate proximal</cell><cell></cell><cell>since age 80</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>weakness in upper extremities</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>*Creatine kinase; mkat/l, normal value &lt;3.5. HLA, human leucocyte antigen.</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"># 2003 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 58, 195-200 13653083, 2003, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1046/j.1365-3083.2003.01251.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [08/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="13653083" xml:id="foot_1">, 2003, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1046/j.1365-3083.2003.01251.x by University Of Illinois At Urbana Champaign, Wiley Online Library on [08/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This study was supported by grants from the Swedish Medical Research Council (Proj. no. 7122), King Gustav V 80th Anniversary Fund, the Swedish Rheumatism Association and the Go ¨teborg Medical Society. Professor Lennart Rydberg is acknowledged for valuable help with HLA typing.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: genetic factors, aberrant protein expression, and autoimmunity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="469" to="475" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Inclusion body myositis -clinical, morphological, physiological and laboratory findings in 18 cases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjo ¨rkander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="123" to="131" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="527" to="533" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="193" to="208" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="112" to="125" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="168" to="173" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="525" to="531" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Myosites a inclusions: mecanismes etiologiques</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="948" to="958" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis: counts of different types of abnormal fibers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Pruitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Showalter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="139" to="143" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="209" to="215" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Limited T-cell receptor V gene usage in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Immunol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2659" to="2663" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The ab T-cell receptor repertoire in inclusion body myositis -diverse patterns of gene expression by muscle-infiltrating lymphocytes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Autoimmun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="321" to="333" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mosavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="185" to="189" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">T cell receptor beta-chain repertoire in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="129" to="134" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">T-cell heterogeneity in muscle lesions of inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="86" to="91" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Griggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="705" to="713" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Sequence analysis of the human alpha beta T-cell receptor CDR3 region</title>
		<author>
			<persName><forename type="first">Pah</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Bell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="10" to="18" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Analysis of T-cell receptor repertoire of muscle-infiltrating T-lymphocytes in polymyositis. Restricted V-alpha/beta rearrangements may indicate antigen-driven selection</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mantegazza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andreetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bernasconi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="2880" to="2886" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Predominant TCR-ab variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="2569" to="2576" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8þ T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iglesias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dornmair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="1863" to="1868" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The expression of co-stimulatory and accessory molecules on cultured human muscle cells is not dependent on stimulus by pro-inflammatory cytokines: relevance for the pathogenesis of inflammatory myopathy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Bernasconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Confalonieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andreetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Baggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cornelio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mantegazza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="52" to="58" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Murata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="453" to="460" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions</title>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kerschensteiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Misgeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="5943" to="5951" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: morphological clues to correct diagnosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Dahlbom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="853" to="857" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Simonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stroncek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="139" to="142" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">HLA associations with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ollier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Rider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Gurley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Pandey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="710" to="719" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lowin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hahne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mattmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tschopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="page" from="650" to="652" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Immunohistochemical analysis of perforin and granzyme a in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Orimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Goto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="219" to="226" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Engelhardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2905" to="2910" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="929" to="938" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Upregulation of Fas/Fas ligand in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="127" to="130" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Expression of Bcl-2 in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="403" to="407" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Hutchinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1742" to="1745" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1205" to="1209" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4þ T cells cause muscle cell injury directly in polymyositis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sugiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Murakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kobayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="291" to="298" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Schro ¨der JM. Differential expression of chemokines in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">De</forename><surname>Bleecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Paepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vanwalleghem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1779" to="1785" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">New developments in the role of cytokines and chemokines in inflammatory myopathies</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nyberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="521" to="529" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Advances in Clinical Neurosciences</title>
				<editor>
			<persName><forename type="first">P</forename><surname>Chandra</surname></persName>
		</editor>
		<meeting><address><addrLine>Ranchi</addrLine></address></meeting>
		<imprint>
			<publisher>The Catholic Press</publisher>
			<date type="published" when="2001">2001</date>
			<biblScope unit="page" from="315" to="333" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tanuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kojima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="509" to="513" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: studies in repeated muscle biopsies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Amemiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="2030" to="2039" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
